FCGRT and telomere syndrome: Given that DOX is the standard therapy for STS as the first-line treatment, we tested the effect of SPEDOX-6 on STS tumor growth using the established HT-1080 xenograft STS mouse model (SCID mice) expressing the lowest level of FcRn (<2 TPM) among cell lines [45].